McKesson Co. (NYSE:MCK) Shares Sold by William B. Walkup & Associates Inc.

William B. Walkup & Associates Inc. reduced its stake in shares of McKesson Co. (NYSE:MCK) by 2.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 6,704 shares of the company’s stock after selling 154 shares during the quarter. McKesson accounts for 2.4% of William B. Walkup & Associates Inc.’s holdings, making the stock its 11th largest position. William B. Walkup & Associates Inc.’s holdings in McKesson were worth $3,821,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently bought and sold shares of MCK. Cibc World Market Inc. lifted its stake in shares of McKesson by 6.3% in the 4th quarter. Cibc World Market Inc. now owns 20,252 shares of the company’s stock valued at $11,542,000 after purchasing an additional 1,207 shares during the period. Brentview Investment Management LLC purchased a new position in McKesson in the fourth quarter valued at $3,018,000. Ingalls & Snyder LLC raised its position in shares of McKesson by 8.2% in the fourth quarter. Ingalls & Snyder LLC now owns 13,824 shares of the company’s stock worth $7,878,000 after acquiring an additional 1,047 shares during the period. Chicago Partners Investment Group LLC boosted its stake in shares of McKesson by 85.0% during the 4th quarter. Chicago Partners Investment Group LLC now owns 1,262 shares of the company’s stock worth $745,000 after acquiring an additional 580 shares in the last quarter. Finally, Blue Trust Inc. grew its position in shares of McKesson by 6.4% during the 4th quarter. Blue Trust Inc. now owns 7,830 shares of the company’s stock valued at $4,462,000 after acquiring an additional 468 shares during the period. 85.07% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

MCK has been the subject of a number of recent analyst reports. Wells Fargo & Company boosted their price objective on McKesson from $641.00 to $691.00 and gave the company an “equal weight” rating in a research report on Friday, March 14th. Evercore ISI lifted their price target on shares of McKesson from $650.00 to $675.00 and gave the company an “outperform” rating in a research note on Thursday, February 6th. Mizuho upped their price objective on shares of McKesson from $630.00 to $690.00 and gave the stock a “neutral” rating in a research report on Thursday, April 3rd. Morgan Stanley increased their price objective on shares of McKesson from $642.00 to $745.00 and gave the company an “overweight” rating in a report on Wednesday, April 2nd. Finally, StockNews.com upgraded shares of McKesson from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, May 13th. Three equities research analysts have rated the stock with a hold rating, eleven have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, McKesson presently has an average rating of “Moderate Buy” and an average target price of $686.69.

McKesson Trading Up 0.3%

MCK opened at $726.05 on Tuesday. McKesson Co. has a twelve month low of $464.42 and a twelve month high of $728.48. The firm has a market capitalization of $90.84 billion, a PE ratio of 33.24, a PEG ratio of 1.29 and a beta of 0.53. The firm’s 50-day moving average price is $684.84 and its 200 day moving average price is $629.90.

McKesson (NYSE:MCK) last issued its earnings results on Thursday, May 8th. The company reported $10.12 earnings per share for the quarter, topping the consensus estimate of $9.83 by $0.29. McKesson had a negative return on equity of 181.26% and a net margin of 0.82%. The business had revenue of $90.82 billion for the quarter, compared to analysts’ expectations of $94 billion. During the same period in the previous year, the firm posted $6.18 EPS. The business’s revenue for the quarter was up 18.9% compared to the same quarter last year. As a group, analysts predict that McKesson Co. will post 32.77 earnings per share for the current fiscal year.

McKesson Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, July 1st. Shareholders of record on Monday, June 2nd will be paid a $0.71 dividend. This represents a $2.84 dividend on an annualized basis and a dividend yield of 0.39%. The ex-dividend date of this dividend is Monday, June 2nd. McKesson’s dividend payout ratio (DPR) is presently 10.99%.

Insider Transactions at McKesson

In other news, CEO Brian S. Tyler sold 8,961 shares of the stock in a transaction that occurred on Friday, February 21st. The shares were sold at an average price of $597.99, for a total value of $5,358,588.39. Following the completion of the sale, the chief executive officer now owns 60,664 shares of the company’s stock, valued at $36,276,465.36. This represents a 12.87% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Insiders own 0.11% of the company’s stock.

McKesson Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.